Structure Therapeutics Inc. (GPCR) stock

GPCRNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$20.00+0.16 (+0.81%)

Close on Nov 13, 2026Market cap $1.43BP/E –Yield –

Structure Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Structure Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?